ReviewPharmaceuticals (Basel, Switzerland)2023

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma.

Anne Laure Giraudet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.